Synonyms: BGB-116673 | BGB116673 | compound 14 [WO2021219070A1]
Compound class:
Synthetic organic
Comment: The chemical structure for catadegbrutinib was derived from WHO proposed INN list 132 (Feb 2025), in which it is listed as a Bruton tyrosine kinase (BTK) degrader with antineoplastic potential. A structure match in PubChem aligns catadegbrutinib with the company research code BGB-116673/BGB116673, and with a structure claimed in Beigene's patent WO2021219070A1 [1]. BGB116673 is a conjugate of a BTK inhibitor with an E3 ligase ligand. As a PROTAC class degrader the resulting molecule functions to recruit targeted proteins to E3 ubiquitin ligase for proteasomal degradation of wild type and mutated forms of the BTK protein.
|
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel